ONTARIO, Calif., Nov. 13, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), today closed its previously announced underwritten public offering of (a) 25,133,631 units (the "Units"), with each Unit consisting of (i) one share of common stock, par value $0.0001 per share (the "Common Stock"), (ii) one Series A Warrant to purchase one share of Common Stock (the "Series A Warrant"), and (iii) one Series B Warrant to purchase such number of shares of Common Stock as determined on the Reset Date (as defined in the Series B Warrant) (the "Series B Warrant"), at a public offering price of $0.1118 per Unit and (b) 1,700,000 pre-funded units (the "Pre-Funded Units"), with each Pre-Funded Unit consisting of (i) one pre-funded warrant exercisable for one share of Common Stock, (ii) one Series A Warrant, and (iii) one Series B Warrant, at a public offering price of $0.1117 per Pre-Funded Unit, for the aggregate gross proceeds of approximately $3 million, prior to deducting underwriting discounts and other offering expenses.
D. Boral Capital LLC ("D. Boral Capital") acted as the sole book running manager for the offering. Sichenzia Ross Ference Carmel LLP acted as legal counsel to the Company, and Lucosky Brookman LLP acted as legal counsel to D. Boral Capital.
The offering was conducted pursuant to the Company's registration statement on Form S-1, as amended on November 6, 2024 (File No. 333-282487), which was initially filed on October 3, 2024 with the Securities and Exchange Commission (the "SEC") and was declared effective by the SEC on November 7, 2024 and the second registration statement on Form S-1 (File No. 333-283079) filed with the SEC on November 7, 2024. A final prospectus relating to the offering has been filed with the SEC and is available on the SEC's website at www.sec.gov. Electronic copies of the final prospectus relating to this offering may be obtained from D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022, Attention: Syndicate Department, or via email at syndicate@dboralcapital.com or telephone at (212) 404-7002.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
What the stars mean:
★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional